Corrigendum: Integrated metabolomics and proteomics reveal biomarkers associated with hemodialysis in end-stage kidney disease

Front Pharmacol. 2024 Feb 9:15:1376058. doi: 10.3389/fphar.2024.1376058. eCollection 2024.

Weiwei Lin^{1

2}, Fatemeh Mousavi¹, Benjamin C Blum^{1

2}, Christian F Heckendorf^{1

2}, Jarrod Moore^{1

2}, Noah Lampl^{1

2}, Mark McComb^{1

2}, Sergei Kotelnikov³, Wenqing Yin⁴, Nabil Rabhi², Matthew D Layne², Dima Kozakov³, Vipul C Chitalia^{4

5

6}, Andrew Emili^{1

2

7}

¹ Center for Network Systems Biology, Boston University, Boston, MA, United States.
² Department of Biochemistry, Boston University School of Medicine, Boston, MA, United States.
³ Department of Applied Mathematics and Statistics, Stony Brook University, Stony Brook, NY, United States.
⁴ Renal Section, Department of Medicine, Boston University School of Medicine, Boston, MA, United States.
⁵ Veterans Affairs Boston Healthcare System, Boston, MA, United States.
⁶ Institute of Medical Engineering and Sciences, Massachusetts Institute of Technology, Cambridge, MA, United States.
⁷ Department of Biology, Boston University, Boston, MA, United States.

Abstract

[This corrects the article DOI: 10.3389/fphar.2023.1243505.].

Keywords: ESKD; integrated omics; metabolomics; nLC-MS/MS; proteomics.